Nebenwirkungen · MabThera
MabThera 100 mg concentrate for solution for infusion MabThera 500 mg concentrate for solution for infusion · Abschnitt 4.8 · PDF-Seite 22–23
HOS-087582 · Präparat HOS-083527
22 MedDRA System Very Common Common Uncommon Rare Very rare Not known Organ Class Investigations decreased IgM decreased IgG levels6 levels6 1 See also section infections below. 2 Observed during post-marketing surveillance 3 Frequency category derived from laboratory values collected as part of routine laboratory monitoring in clinical trials 4 Frequency category derived from post-marketing data. 5 Reactions occurring during or within 24 hours of infusion. See also infusion-related reactions below. IRRs may occur as a
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-08-06T15:15:00Z · SHA-256 595c4e1a263e9a34be8b62842a5fc67f95f6a1b1f2a250341444a2960c6c3962 · Passage 53ab3f28b35fd7b2bb2a0262aa003317c1cff89858556951fbe2773f6a0f71c3 · Zeichen 32300–32950 im Abschnitt